ClinicalTrials HQ

Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc.

Explore linked clinical trials.

5 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis SuppurativaBacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorderRecruitingPhase 22026-09-24NCT07783542
An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisPlaque PsoriasisRecruitingPhase 22026-09-23NCT07449702
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisPlaque PsoriasisActive, not recruitingPhase 22026-08-17NCT07290569
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisPlaque PsoriasisRecruitingPhase 22026-08-10NCT07474792
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisPlaque PsoriasisActive, not recruitingPhase 22026-07-01NCT07090330